Your browser doesn't support javascript.
loading
Standardized evidence-based approach for assessment of oncogenic and clinical significance of NTRK fusions.
Saliba, Jason; Church, Alanna J; Rao, Shruti; Danos, Arpad; Furtado, Larissa V; Laetsch, Theodore; Zhang, Liying; Nardi, Valentina; Lin, Wan-Hsin; Ritter, Deborah I; Madhavan, Subha; Li, Marilyn M; Griffith, Obi L; Griffith, Malachi; Raca, Gordana; Roy, Angshumoy.
  • Saliba J; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO United States.
  • Church AJ; Department of Pathology, Boston Children's Hospital and Harvard Medical School, Boston, MA, United States.
  • Rao S; Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington D.C., United States.
  • Danos A; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO United States.
  • Furtado LV; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, United States.
  • Laetsch T; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Zhang L; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA, United States.
  • Nardi V; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Lin WH; Department of Cancer Biology, Mayo Clinic Florida, Jacksonville, FL, United States.
  • Ritter DI; Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States.
  • Madhavan S; Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington D.C., United States; AstraZeneca, Cambridge, United Kingdom.
  • Li MM; Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States.
  • Griffith OL; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO United States.
  • Griffith M; Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO United States.
  • Raca G; Department of Pathology and Laboratory Medicine, Children's Hospital of Los Angeles, Los Angeles, CA, United States.
  • Roy A; Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, United States; Department of Pathology & Immunology, Baylor College of Medicine, Houston, TX, United States; Department of Pathology, Texas Children's Hospital, Houston, TX, United States. Electronic
Cancer Genet ; 264-265: 50-59, 2022 06.
Article en En | MEDLINE | ID: mdl-35366592
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor trkA / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Child / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor trkA / Neoplasias Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Child / Humans Idioma: En Año: 2022 Tipo del documento: Article